Becerra M, John G, Drepper M, Marti C, Darbellay P, Perrier A, Carballo S
Service de médecine interne générale, HUG, 1211 Genève 14.
Rev Med Suisse. 2012 Feb 1;8(326):259-63.
Numerous prospective randomised trials recently demonstrated the importance of an aggressive approach towards controlling cardiovascular risk factors. New studies reinforce the plethora of available data and confirm that interventional revascularisation strategies for stable coronary heart disease or cerebral vascular disease offer few benefits as compared to medical treatment, and can even lead to worse outcomes. This selective review describes some recent studies in the areas of cardiovascular disease, pulmonary disease, such as chronic obstructive pulmonary disease or screening of lung cancer, and gastroenterology.
